(Q34596985)

English

Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma

scientific article

Statements

Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma (English)
6 September 2008

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit